Lauren A. Baldassarre, MD, FACC
Associate Professor of Medicine (Cardiovascular Medicine); Vice Chief, Cardiovascular Medicine, Faculty Life, Cardiovascular Medicine; Cardiology Director of Cardiac MR/CT, Advanced Cardiovascular CT/MR Program; Director, Cardio-Oncology, Cardiovascular Medicine; Director, Cardio-Oncology Advanced Training Fellowship Program, Cardiovascular Medicine; Vice Chief of Diversity, Equity and Inclusion, Cardiovascular Medicine
Research & Publications
Biography
News
Coauthors
Selected Publications
- Multimodality Evaluation of Spontaneous Coronary Artery Dissection in a Patient With Connective Tissue Disease: A Case ReportShah T, Shah N, Baldassarre L, Freed L, Mojibian H, Shah S. Multimodality Evaluation of Spontaneous Coronary Artery Dissection in a Patient With Connective Tissue Disease: A Case Report. Journal Of The Society For Cardiovascular Angiography & Interventions 2023, 2: 101125. DOI: 10.1016/j.jscai.2023.101125.
- SGLT2 Inhibitor Use and Risk of Clinical Events in Patients With Cancer Therapy–Related Cardiac DysfunctionAvula V, Sharma G, Kosiborod M, Vaduganathan M, Neilan T, Lopez T, Dent S, Baldassarre L, Scherrer-Crosbie M, Barac A, Liu J, Deswal A, Khadke S, Yang E, Ky B, Lenihan D, Nohria A, Dani S, Ganatra S. SGLT2 Inhibitor Use and Risk of Clinical Events in Patients With Cancer Therapy–Related Cardiac Dysfunction. JACC Heart Failure 2023, 12: 67-78. PMID: 37897456, DOI: 10.1016/j.jchf.2023.08.026.
- Atrial fibrosis by cardiac MRI is a correlate for atrial stiffness in patients with atrial fibrillationLamy J, Taoutel R, Chamoun R, Akar J, Niederer S, Mojibian H, Huber S, Baldassarre L, Meadows J, Peters D. Atrial fibrosis by cardiac MRI is a correlate for atrial stiffness in patients with atrial fibrillation. The International Journal Of Cardiovascular Imaging 2023, 40: 107-117. PMID: 37857929, DOI: 10.1007/s10554-023-02968-x.
- Scientific document development standards for the society of cardiovascular computed tomography (SCCT): A statement from the SCCT Guidelines CommitteeBaldassarre L, Koweek L, Andreini D, Branch K, Brennaman D, Budde R, De La O S, Fairbairn T, Hedgire S, Weir-McCall J, Woodard P, Wong D, Chen M, Committee S. Scientific document development standards for the society of cardiovascular computed tomography (SCCT): A statement from the SCCT Guidelines Committee. Journal Of Cardiovascular Computed Tomography 2023, 17: 459-464. PMID: 37429770, DOI: 10.1016/j.jcct.2023.06.006.
- Quantitative cardiovascular magnetic resonance findings and clinical risk factors predict cardiovascular outcomes in breast cancer patientsKwan J, Arbune A, Henry M, Hu R, Wei W, Nguyen V, Lee S, Lopez-Mattei J, Guha A, Huber S, Bader A, Meadows J, Sinusas A, Mojibian H, Peters D, Lustberg M, Hull S, Baldassarre L. Quantitative cardiovascular magnetic resonance findings and clinical risk factors predict cardiovascular outcomes in breast cancer patients. PLOS ONE 2023, 18: e0286364. PMID: 37252927, PMCID: PMC10228774, DOI: 10.1371/journal.pone.0286364.
- Advances in Coronary Computed Tomographic Angiographic Imaging of Atherosclerosis for Risk Stratification and Preventive CareBienstock S, Lin F, Blankstein R, Leipsic J, Cardoso R, Ahmadi A, Gelijns A, Patel K, Baldassarre L, Hadley M, LaRocca G, Sanz J, Narula J, Chandrashekhar Y, Shaw L, Fuster V. Advances in Coronary Computed Tomographic Angiographic Imaging of Atherosclerosis for Risk Stratification and Preventive Care. JACC Cardiovascular Imaging 2023, 16: 1099-1115. PMID: 37178070, DOI: 10.1016/j.jcmg.2023.02.002.
- Impaired left-ventricular global longitudinal strain by feature-tracking cardiac MRI predicts mortality in systemic sclerosisFeher A, Miller E, Peters D, Mojibian H, Sinusas A, Hinchcliff M, Baldassarre L. Impaired left-ventricular global longitudinal strain by feature-tracking cardiac MRI predicts mortality in systemic sclerosis. Rheumatology International 2023, 43: 849-858. PMID: 36894756, DOI: 10.1007/s00296-023-05294-6.
- Racial and Ethnic Disparities in All-Cause and Cardiovascular Mortality Among Cancer Patients in the U.S.Zhu C, Shi T, Jiang C, Liu B, Baldassarre L, Zarich S. Racial and Ethnic Disparities in All-Cause and Cardiovascular Mortality Among Cancer Patients in the U.S. JACC CardioOncology 2023, 5: 55-66. PMID: 36875907, PMCID: PMC9982284, DOI: 10.1016/j.jaccao.2022.10.013.
- Myocardial Injury on CMR in Patients With COVID-19 and Suspected Cardiac InvolvementVidula M, Rajewska-Tabor J, Cao J, Kang Y, Craft J, Mei W, Chandrasekaran P, Clark D, Poenar A, Gorecka M, Malahfji M, Cowan E, Kwan J, Reinhardt S, Al-Tabatabaee S, Doeblin P, Villa A, Karagodin I, Alvi N, Christia P, Spetko N, Cassar M, Park C, Nambiar L, Turgut A, Azad M, Lambers M, Wong T, Salerno M, Kim J, Elliott M, Raman B, Neubauer S, Tsao C, LaRocca G, Patel A, Chiribiri A, Kelle S, Baldassarre L, Shah D, Hughes S, Tong M, Pyda M, Simonetti O, Plein S, Han Y. Myocardial Injury on CMR in Patients With COVID-19 and Suspected Cardiac Involvement. JACC Cardiovascular Imaging 2023, 16: 609-624. PMID: 36752429, PMCID: PMC9833283, DOI: 10.1016/j.jcmg.2022.10.021.
- Women physicians in cardiovascular magnetic resonance: Past, present, and futureSierra-Galan L, Aggarwal N, Stojanovska J, Raman S, Han Y, Ferreira V, Thomas K, Seiberlich N, Parwani P, Bucciarelli-Ducci C, Baldassarre L, Mavrogeni S, Ordovas K, Schulz-Menger J, Bandettini W. Women physicians in cardiovascular magnetic resonance: Past, present, and future. Frontiers In Cardiovascular Medicine 2023, 9: 984326. PMID: 36684587, PMCID: PMC9848434, DOI: 10.3389/fcvm.2022.984326.
- Abstract 11850: Association Between SGLT2 Inhibitor Use and Risk of Clinical Events in Patients With Antineoplastic Therapy Associated Cardiomyopathy and Heart FailureAvula V, Sharma G, Kosiborod M, Vaduganathan M, Neilan T, Lopez-Fernandez T, Dent S, Baldassarre L, Scherrer-Crosbie M, Scherrer-crosbie M, Barac A, Liu J, Deswal A, Yang E, Ky B, Lenihan D, Lenihan D, Nohria A, Nohria A, Dani S, Ganatra S. Abstract 11850: Association Between SGLT2 Inhibitor Use and Risk of Clinical Events in Patients With Antineoplastic Therapy Associated Cardiomyopathy and Heart Failure. Circulation 2022, 146: a11850-a11850. DOI: 10.1161/circ.146.suppl_1.11850.
- Abstract 13769: AT1R Autoantibody Levels Are Elevated in Patients Who Required Immunosuppression Escalation in Immune Checkpoint Inhibitor Mediated MyocarditisAkhlaghi N, Shen M, Bow L, Miller M, Hwa J, Halene S, Baldassarre L, Kwan J. Abstract 13769: AT1R Autoantibody Levels Are Elevated in Patients Who Required Immunosuppression Escalation in Immune Checkpoint Inhibitor Mediated Myocarditis. Circulation 2022, 146: a13769-a13769. DOI: 10.1161/circ.146.suppl_1.13769.
- Advances in Multimodality Imaging in Cardio-Oncology JACC State-of-the-Art ReviewBaldassarre LA, Ganatra S, Lopez-Mattei J, Yang EH, Zaha VG, Wong TC, Ayoub C, DeCara JM, Dent S, Deswal A, Ghosh AK, Henry M, Khemka A, Leja M, Rudski L, Villarraga HR, Liu JE, Barac A, Scherrer-Crosbie M, Councils A. Advances in Multimodality Imaging in Cardio-Oncology JACC State-of-the-Art Review. Journal Of The American College Of Cardiology 2022, 80: 1560-1578. PMID: 36229093, DOI: 10.1016/j.jacc.2022.08.743.
- Impact of Social Vulnerability on Comorbid Cancer and Cardiovascular Disease Mortality in the United StatesGanatra S, Dani SS, Kumar A, Khan SU, Wadhera R, Neilan TG, Thavendiranathan P, Barac A, Hermann J, Leja M, Deswal A, Fradley M, Liu JE, Sadler D, Asnani A, Baldassarre LA, Gupta D, Yang E, Guha A, Brown SA, Stevens J, Hayek SS, Porter C, Kalra A, Baron SJ, Ky B, Virani SS, Kazi D, Nasir K, Nohria A. Impact of Social Vulnerability on Comorbid Cancer and Cardiovascular Disease Mortality in the United States. JACC CardioOncology 2022, 4: 326-337. PMID: 36213357, PMCID: PMC9537091, DOI: 10.1016/j.jaccao.2022.06.005.
- Cardiac computed tomographic imaging in cardio-oncology: An expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT). Endorsed by the International Cardio-Oncology Society (ICOS)Lopez-Mattei J, Yang EH, Baldassarre LA, Agha A, Blankstein R, Choi AD, Chen MY, Meyersohn N, Daly R, Slim A, Rochitte C, Blaha M, Whelton S, Dzaye O, Dent S, Milgrom S, Ky B, Iliescu C, Mamas MA, Ferencik M. Cardiac computed tomographic imaging in cardio-oncology: An expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT). Endorsed by the International Cardio-Oncology Society (ICOS). Journal Of Cardiovascular Computed Tomography 2022, 17: 66-83. PMID: 36216699, DOI: 10.1016/j.jcct.2022.09.002.
- Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis: Report from an international registryNowatzke J, Guedeney P, Palaskas N, Lehmann L, Ederhy S, Zhu H, Cautela J, Francis S, Courand PY, Deswal A, Ewer SM, Aras M, Arangalage D, Ghafourian K, Fenioux C, Finke D, Peretto G, Zaha V, Zadok O, Tajiri K, Akhter N, Levenson J, Baldassarre L, Power J, Huang S, Collet JP, Moslehi J, Salem JE, contributors I, Aghel N, Alexandre J, Aonuma K, Asnani A, Behling J, Bilen M, Bottinor W, Cariou E, Chahine J, Chan W, Chauhan A, Cohen M, Crusz S, Fernando S, Florido R, Frigeri M, Fukushima S, Gaughan E, Geisler B, Gilstrap L, Grohe C, Guha A, Habib M, Haegler-Laube E, Haydon A, Hayek S, Hughes A, Imai R, Katsume Y, Kimura H, Lin L, Lenneman C, Leong D, Makker V, Martinez-Calle N, Moey M, Mohri M, Morimoto R, Moritoki Y, Narezkina A, Nicol M, Nooka A, Orimoloye O, Patel M, Perl M, Piriou N, Raikhelkar J, Raza Y, Rao A, Reddy S, Seki N, Stangl K, Stewart A, Stringer B, Tamarappoo B, Tamura Y, Thuny F, Tierney S, Tresorier R, Ullah W, Von Hunolstein J, Warner E, Weppler A. Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis: Report from an international registry. European Journal Of Cancer 2022, 177: 197-205. PMID: 36030143, PMCID: PMC10165738, DOI: 10.1016/j.ejca.2022.07.018.
- Short-Term Outcomes After Myopericarditis Related to COVID-19 VaccinationPareek M, Steele J, Asnes J, Baldassarre L, Casale L, Desai N, Elder R, Faherty E, Ferguson I, Fishman R, Ghazizadeh Z, Glick L, Hall E, Khera R, Kokkinidis D, Kwan J, O'Marr J, Schussheim A, Tuohy E, Wang Y, Spatz E, Jacoby D, Miller E. Short-Term Outcomes After Myopericarditis Related to COVID-19 Vaccination. JACC Cardiovascular Imaging 2022, 15: 2002-2005. PMID: 36357140, PMCID: PMC9094612, DOI: 10.1016/j.jcmg.2022.03.026.
- Novel Cardiac Computed Tomography Methods for the Assessment of Anthracycline Induced CardiotoxicityFeher A, Baldassarre LA, Sinusas AJ. Novel Cardiac Computed Tomography Methods for the Assessment of Anthracycline Induced Cardiotoxicity. Frontiers In Cardiovascular Medicine 2022, 9: 875150. PMID: 35571206, PMCID: PMC9094702, DOI: 10.3389/fcvm.2022.875150.
- Cardiovascular safety profile of taxanes and vinca alkaloids: 30 years FDA registry experienceBatra A, Patel B, Addison D, Baldassarre LA, Desai N, Weintraub N, Deswal A, Hussain Z, Brown SA, Ganatra S, Agarwala V, Parikh PM, Fradley M, Ghosh A, Guha A. Cardiovascular safety profile of taxanes and vinca alkaloids: 30 years FDA registry experience. Open Heart 2021, 8: e001849. PMID: 34952868, PMCID: PMC8710909, DOI: 10.1136/openhrt-2021-001849.
- Cardiac Computed Tomography in Cardio-Oncology JACC: CardioOncology PrimerLopez-Mattei JC, Yang EH, Ferencik M, Baldassarre LA, Dent S, Budoff MJ. Cardiac Computed Tomography in Cardio-Oncology JACC: CardioOncology Primer. JACC CardioOncology 2021, 3: 635-649. PMID: 34988472, PMCID: PMC8702811, DOI: 10.1016/j.jaccao.2021.09.010.
- Abstract 12757: Impact of Social Vulnerability on Cardio-Oncology Mortality in the United StatesGanatra S, Dani S, Kumar A, Khan S, Neilan T, Thavendiranathan P, Barac A, Hermann J, Leja M, Deswal A, Fradley M, Liu J, Ky B, Sadler D, Asnani A, Baldassarre L, Gupta D, Yang E, Guha A, Brown S, Wadhera R, Kazi D, Stevens J, Hayek S, Baron S, Nasir K, Nohria A. Abstract 12757: Impact of Social Vulnerability on Cardio-Oncology Mortality in the United States. Circulation 2021, 144: a12757-a12757. DOI: 10.1161/circ.144.suppl_1.12757.
- Left atrial evaluation by cardiovascular magnetic resonance: sensitive and unique biomarkersPeters DC, Lamy J, Sinusas AJ, Baldassarre LA. Left atrial evaluation by cardiovascular magnetic resonance: sensitive and unique biomarkers. European Heart Journal - Cardiovascular Imaging 2021, 23: 14-30. PMID: 34718484, PMCID: PMC8685602, DOI: 10.1093/ehjci/jeab221.
- Clinical Impact of Cardiovascular Magnetic Resonance in Cancer Patients With Suspected CardiomyopathyHeidari-Bateni G, Durand J, Iliescu C, Gladish G, Deswal A, Patel A, Kim P, Song J, Hassan S, Palaskas N, Baldassarre L, Bucciarelli-Ducci C, Lopez-Mattei J. Clinical Impact of Cardiovascular Magnetic Resonance in Cancer Patients With Suspected Cardiomyopathy. Frontiers In Cardiovascular Medicine 2021, 8: 734820. PMID: 34765654, PMCID: PMC8576269, DOI: 10.3389/fcvm.2021.734820.
- Are cardiology fellows receiving enough basic level I cardiovascular computed tomography education during their general fellowship training? Insights from a needs assessment survey at an academic medical centerHur DJ, Meadows JL, Baldassarre LA, Mojibian HR, Villines TC, Windish DM. Are cardiology fellows receiving enough basic level I cardiovascular computed tomography education during their general fellowship training? Insights from a needs assessment survey at an academic medical center. Journal Of Cardiovascular Computed Tomography 2021, 16: 186-188. PMID: 34600865, DOI: 10.1016/j.jcct.2021.09.005.
- Adverse cardiovascular events in patients treated with mogamulizumabKwan J, Henry M, Cook K, Higgins A, Cuomo J, Foss F, Baldassarre L. Adverse cardiovascular events in patients treated with mogamulizumab. American Heart Journal Plus Cardiology Research And Practice 2021, 9: 100049. PMCID: PMC10978139, DOI: 10.1016/j.ahjo.2021.100049.
- Rationale and proposed framework for shared decision making in cardio-oncologyHull SC, Soufer A, Spatz ES, Baldassarre LA. Rationale and proposed framework for shared decision making in cardio-oncology. Cardio-Oncology 2021, 7: 30. PMID: 34425913, PMCID: PMC8380868, DOI: 10.1186/s40959-021-00118-7.
- Adverse thrombo-embolic events with newer tyrosine kinase inhibitors: a call to action for better risk stratification and monitoringHussain Z, Baldassarre L, Dent S, Weintraub NL, Guha A. Adverse thrombo-embolic events with newer tyrosine kinase inhibitors: a call to action for better risk stratification and monitoring. European Journal Of Preventive Cardiology 2021, 29: 1309-1311. PMID: 34219160, DOI: 10.1093/eurjpc/zwab055.
- Are Cardiology Fellows Receiving Enough Baseline Level I Cardiovascular Computed Tomography Education During Their General Fellowship Training? Insights From An Academic Medical CenterHur D, Meadows J, Baldassarre L, Mojibian H, Villines T, Windish D. Are Cardiology Fellows Receiving Enough Baseline Level I Cardiovascular Computed Tomography Education During Their General Fellowship Training? Insights From An Academic Medical Center. Journal Of Cardiovascular Computed Tomography 2021, 15: s40-s41. DOI: 10.1016/j.jcct.2021.06.251.
- Cardiac Magnetic Resonance in Cardio-Oncology Advantages, Importance of Expediency, and Considerations to Navigate Pre-AuthorizationO’Quinn R, Ferrari VA, Daly R, Hundley G, Baldassarre LA, Han Y, Barac A, Arnold A. Cardiac Magnetic Resonance in Cardio-Oncology Advantages, Importance of Expediency, and Considerations to Navigate Pre-Authorization. JACC CardioOncology 2021, 3: 191-200. PMID: 34396324, PMCID: PMC8352183, DOI: 10.1016/j.jaccao.2021.04.011.
- Mogamulizumab-Associated Acute Myocarditis in a Patient With T-Cell LymphomaKwan JM, Odanovic N, Arbune A, Higgins A, Henry M, Greif D, Foss F, Baldassarre LA. Mogamulizumab-Associated Acute Myocarditis in a Patient With T-Cell Lymphoma. JACC Case Reports 2021, 3: 1018-1023. PMID: 34317676, PMCID: PMC8311348, DOI: 10.1016/j.jaccas.2021.04.001.
- Fat-saturated dark-blood cardiac T2 mapping in a single breath-holdHu C, Huber S, Nguyen V, Baldassarre L, Mojibian H, Peters D. Fat-saturated dark-blood cardiac T2 mapping in a single breath-hold. Magnetic Resonance Imaging 2021, 81: 24-32. PMID: 34044065, DOI: 10.1016/j.mri.2021.05.004.
- Outcomes in patients with anthracycline‐induced cardiomyopathy undergoing left ventricular assist devices implantationGuha A, Caraballo C, Jain P, Miller PE, Owusu‐Guha J, Clark KAA, Velazquez EJ, Ahmad T, Baldassarre LA, Addison D, Weintraub NL, Desai NR. Outcomes in patients with anthracycline‐induced cardiomyopathy undergoing left ventricular assist devices implantation. ESC Heart Failure 2021, 8: 2866-2875. PMID: 33982867, PMCID: PMC8318466, DOI: 10.1002/ehf2.13362.
- CARDIOVASCULAR AND MORTALITY OUTCOMES IN ONCOLOGY PATIENTS HOSPITALIZED WITH COVID-19Kwan J, Lee S, Tao W, Wei W, Simonov M, Halene S, Hwa J, Baldassarre L. CARDIOVASCULAR AND MORTALITY OUTCOMES IN ONCOLOGY PATIENTS HOSPITALIZED WITH COVID-19. Journal Of The American College Of Cardiology 2021, 77: 3294. PMCID: PMC8091382, DOI: 10.1016/s0735-1097(21)04648-9.
- CARDIOVASCULAR SAFETY PROFILE OF TAXANES AND VINCA ALKALOIDS: 30-YEARS FDA REGISTRY EXPERIENCEBatra A, Patel B, Addison D, Baldassarre L, Desai N, Weintraub N, Deswal A, Hussain Z, Brown S, Ganatra S, Agarwala V, Parikh P, Fradley M, Ghosh A, Guha A. CARDIOVASCULAR SAFETY PROFILE OF TAXANES AND VINCA ALKALOIDS: 30-YEARS FDA REGISTRY EXPERIENCE. Journal Of The American College Of Cardiology 2021, 77: 3284. DOI: 10.1016/s0735-1097(21)04638-6.
- 57884 Fast strain-encoded cardiac magnetic resonance detects immune checkpoint inhibitor associated cardiotoxicityCuomo J, Ragheb E, Feher A, Kwan J, Huber S, Mojibian H, Peters D, Sinusas A, Baldassarre L. 57884 Fast strain-encoded cardiac magnetic resonance detects immune checkpoint inhibitor associated cardiotoxicity. Journal Of Clinical And Translational Science 2021, 5: 141-142. PMCID: PMC8827987, DOI: 10.1017/cts.2021.761.
- Aortic Delamination—A Possible Precursor of Impending CatastropheSaeyeldin A, Zafar MA, Baldassarre LA, Mojibian H, Ziganshin BA, Mukherjee SK, Elefteriades JA. Aortic Delamination—A Possible Precursor of Impending Catastrophe. International Journal Of Angiology 2021, 30: 160-164. PMID: 34054275, PMCID: PMC8159620, DOI: 10.1055/s-0040-1718546.
- Cardiovascular magnetic resonance in women with cardiovascular disease: position statement from the Society for Cardiovascular Magnetic Resonance (SCMR)Ordovas KG, Baldassarre LA, Bucciarelli-Ducci C, Carr J, Fernandes JL, Ferreira VM, Frank L, Mavrogeni S, Ntusi N, Ostenfeld E, Parwani P, Pepe A, Raman SV, Sakuma H, Schulz-Menger J, Sierra-Galan LM, Valente AM, Srichai MB. Cardiovascular magnetic resonance in women with cardiovascular disease: position statement from the Society for Cardiovascular Magnetic Resonance (SCMR). Journal Of Cardiovascular Magnetic Resonance 2021, 23: 52. PMID: 33966639, PMCID: PMC8108343, DOI: 10.1186/s12968-021-00746-z.
- Left ventricular myocardial strain and tissue characterization by cardiac magnetic resonance imaging in immune checkpoint inhibitor associated cardiotoxicityHiggins AY, Arbune A, Soufer A, Ragheb E, Kwan JM, Lamy J, Henry M, Cuomo JR, Charifa A, Gallegos C, Hull S, Coviello JS, Bader AS, Peters DC, Huber S, Mojibian HR, Sinusas AJ, Kluger H, Baldassarre LA. Left ventricular myocardial strain and tissue characterization by cardiac magnetic resonance imaging in immune checkpoint inhibitor associated cardiotoxicity. PLOS ONE 2021, 16: e0246764. PMID: 33606757, PMCID: PMC7895343, DOI: 10.1371/journal.pone.0246764.
- Perspectives on the COVID-19 pandemic impact on cardio-oncology: results from the COVID-19 International Collaborative Network surveySadler D, DeCara JM, Herrmann J, Arnold A, Ghosh AK, Abdel-Qadir H, Yang EH, Szmit S, Akhter N, Leja M, Silva CMPDC, Raikhelkar J, Brown SA, Dent S, O’Quinn R, Thuny F, Moudgil R, Raez LE, Okwuosa T, Daniele A, Bauer B, Kondapalli L, Ismail-Khan R, Lax J, Blaes A, Nahleh Z, Elson L, Baldassarre LA, Zaha V, Rao V, Lara DS, Skurka K. Perspectives on the COVID-19 pandemic impact on cardio-oncology: results from the COVID-19 International Collaborative Network survey. Cardio-Oncology 2020, 6: 28. PMID: 33292763, PMCID: PMC7691954, DOI: 10.1186/s40959-020-00085-5.
- Abstract 14563: Improved Outcomes in Patients With Anthracycline-Induced Cardiomyopathy Undergoing Left Ventricular Assist Devices: 10-Year Longitudinal INTERMACS StudyGuha A, Caraballo C, Miller E, Owusu-Guha J, Clark K, Ahmad T, Baldassarre L, Addison D, Weintraub N, Desai N. Abstract 14563: Improved Outcomes in Patients With Anthracycline-Induced Cardiomyopathy Undergoing Left Ventricular Assist Devices: 10-Year Longitudinal INTERMACS Study. Circulation 2020, 142 DOI: 10.1161/circ.142.suppl_3.14563.
- Cardiovascular care of the oncology patient during COVID-19: An expert consensus document from the ACC Cardio-Oncology and Imaging CouncilsBaldassarre LA, Yang EH, Cheng RK, DeCara JM, Dent S, Liu JE, Rudski LG, Strom JB, Thavendiranathan P, Barac A, Zaha VG, Bucciarelli-Ducci C, Ellahham S, Deswal A, Lenneman C, Villarraga HR, Blaes AH, Ismail-Khan R, Ky B, Leja MJ, Scherrer-Crosbie M. Cardiovascular care of the oncology patient during COVID-19: An expert consensus document from the ACC Cardio-Oncology and Imaging Councils. Journal Of The National Cancer Institute 2020, 113: djaa177-. PMID: 33179744, PMCID: PMC7717327, DOI: 10.1093/jnci/djaa177.
- Cardiac Biventricular Metastasis From Renal Cell CarcinomaLatifi AN, Ibe U, Arbune A, Kluger H, Baldassarre LA. Cardiac Biventricular Metastasis From Renal Cell Carcinoma. Cureus 2020, 12: e10870. PMID: 33178523, PMCID: PMC7652367, DOI: 10.7759/cureus.10870.
- Opportunities for improved cardiovascular disease prevention in oncology patients.Bravo-Jaimes K, Marcellon R, Varanitskaya L, Kim PY, Iliescu C, Gilchrist SC, Baldassarre LA, Manisty C, Ghosh AK, Guha A, Lopez-Mattei JC. Opportunities for improved cardiovascular disease prevention in oncology patients. Current Opinion In Cardiology 2020, 35: 531-537. PMID: 32649353, DOI: 10.1097/hco.0000000000000767.
- Clinical and Advanced MRI Techniques for Detection of Checkpoint Inhibitor Associated MyocarditisArbune A, Soufer A, Baldassarre L. Clinical and Advanced MRI Techniques for Detection of Checkpoint Inhibitor Associated Myocarditis. Current Cardiovascular Imaging Reports 2020, 13: 3. DOI: 10.1007/s12410-019-9521-5.
- Cardiovascular disease in women: insights from magnetic resonance imagingBucciarelli-Ducci C, Ostenfeld E, Baldassarre LA, Ferreira VM, Frank L, Kallianos K, Raman SV, Srichai MB, McAlindon E, Mavrogeni S, Ntusi NAB, Schulz-Menger J, Valente AM, Ordovas KG. Cardiovascular disease in women: insights from magnetic resonance imaging. Journal Of Cardiovascular Magnetic Resonance 2020, 22: 71. PMID: 32981527, PMCID: PMC7520984, DOI: 10.1186/s12968-020-00666-4.
- Valvular imaging in the era of feature‐tracking: A slice‐following cardiac MR sequence to measure mitral flowSeemann F, Heiberg E, Carlsson M, Gonzales RA, Baldassarre LA, Qiu M, Peters DC. Valvular imaging in the era of feature‐tracking: A slice‐following cardiac MR sequence to measure mitral flow. Journal Of Magnetic Resonance Imaging 2019, 51: 1412-1421. PMID: 31654470, PMCID: PMC7217167, DOI: 10.1002/jmri.26971.
- Presentation of Liver Failure From a Pericardial MassNguyen VQ, Workman V, Stendahl K, Young L, Sklar J, Baldassarre LA. Presentation of Liver Failure From a Pericardial Mass. Circulation Cardiovascular Imaging 2019, 12: e008672. PMID: 31167559, DOI: 10.1161/circimaging.118.008672.
- The Role of Cardiac Magnetic Resonance Imaging to Detect Cardiac Toxicity From Cancer TherapeuticsSoufer A, Baldassarre LA. The Role of Cardiac Magnetic Resonance Imaging to Detect Cardiac Toxicity From Cancer Therapeutics. Current Treatment Options In Cardiovascular Medicine 2019, 21: 28. PMID: 31104180, DOI: 10.1007/s11936-019-0732-5.
- Nuclear cardiology in the context of multimodality imaging to detect cardiac toxicity from cancer therapeutics: Established and emerging methodsSoufer A, Liu C, Henry ML, Baldassarre LA. Nuclear cardiology in the context of multimodality imaging to detect cardiac toxicity from cancer therapeutics: Established and emerging methods. Journal Of Nuclear Cardiology 2019, 27: 1210-1224. PMID: 30868378, DOI: 10.1007/s12350-019-01671-6.
- A CASE OF PEMBROLIZUMAB INDUCED FULMINANT MYOCARDITISShkolnik E, Ganeshan R, Clarke J, Hull S, Baldassarre L. A CASE OF PEMBROLIZUMAB INDUCED FULMINANT MYOCARDITIS. Journal Of The American College Of Cardiology 2019, 73: 2493. DOI: 10.1016/s0735-1097(19)33099-2.
- CARDIAC MAGNETIC RESONANCE IMAGING FEATURE TRACKING STRAIN AS A SENSITIVE MARKER OF CARDIOTOXICITY IN BREAST CANCER PATIENTS COMPARED WITH LEFT VENTRICULAR EJECTION FRACTIONKwan J, Arbune A, Henry M, Dupee D, Soufer A, Baldassarre L. CARDIAC MAGNETIC RESONANCE IMAGING FEATURE TRACKING STRAIN AS A SENSITIVE MARKER OF CARDIOTOXICITY IN BREAST CANCER PATIENTS COMPARED WITH LEFT VENTRICULAR EJECTION FRACTION. Journal Of The American College Of Cardiology 2019, 73: 1666. DOI: 10.1016/s0735-1097(19)32272-7.
- A CURIOUS CASE OF MYOPERICARDITISO'Brien C, Haghighat L, Higgins A, Arbune A, Baldassarre L. A CURIOUS CASE OF MYOPERICARDITIS. Journal Of The American College Of Cardiology 2019, 73: 2500. DOI: 10.1016/s0735-1097(19)33106-7.
- Left atrial fibrosis correlates with extent of left ventricular myocardial delayed enhancement and left ventricular strain in hypertrophic cardiomyopathyLatif SR, Nguyen VQ, Peters DC, Soufer A, Henry ML, Grunseich K, Testani J, Hur DJ, Huber S, Mojibian H, Dicks D, Sinusas AJ, Meadows JL, Papoutsidakis N, Jacoby D, Baldassarre LA. Left atrial fibrosis correlates with extent of left ventricular myocardial delayed enhancement and left ventricular strain in hypertrophic cardiomyopathy. The International Journal Of Cardiovascular Imaging 2019, 35: 1309-1318. PMID: 30790116, DOI: 10.1007/s10554-019-01551-7.
- Using FDG-PET to guide targeted cardiac magnetic resonance imaging in patients with suspected cardiac sarcoidosisSharp MB, Soufer A, Abdelmessih M, Rosenfeld LE, Baldassarre LA, Miller EJ. Using FDG-PET to guide targeted cardiac magnetic resonance imaging in patients with suspected cardiac sarcoidosis. Journal Of Nuclear Cardiology 2019, 27: 688-690. PMID: 30737635, DOI: 10.1007/s12350-019-01640-z.
- Myocarditis with checkpoint inhibitor immunotherapy: case report of late gadolinium enhancement on cardiac magnetic resonance with pathology correlateGallegos C, Rottmann D, Nguyen VQ, Baldassarre LA. Myocarditis with checkpoint inhibitor immunotherapy: case report of late gadolinium enhancement on cardiac magnetic resonance with pathology correlate. European Heart Journal - Case Reports 2019, 3: yty149. PMID: 31020225, PMCID: PMC6439394, DOI: 10.1093/ehjcr/yty149.
- Prognostic and functional implications of left atrial late gadolinium enhancement cardiovascular magnetic resonanceQuail M, Grunseich K, Baldassarre LA, Mojibian H, Marieb MA, Cornfeld D, Soufer A, Sinusas AJ, Peters DC. Prognostic and functional implications of left atrial late gadolinium enhancement cardiovascular magnetic resonance. Journal Of Cardiovascular Magnetic Resonance 2019, 21: 2. PMID: 30602395, PMCID: PMC6317232, DOI: 10.1186/s12968-018-0514-3.
- REPAIRit: Improving Myocardial Nulling and Ghosting Artifacts of 3D Navigator‐Gated Late Gadolinium Enhancement Imaging During ArrhythmiaHu C, Huber S, Latif SR, Santacana‐Laffitte G, Mojibian HR, Baldassarre LA, Peters DC. REPAIRit: Improving Myocardial Nulling and Ghosting Artifacts of 3D Navigator‐Gated Late Gadolinium Enhancement Imaging During Arrhythmia. Journal Of Magnetic Resonance Imaging 2018, 49: 688-699. PMID: 30252987, DOI: 10.1002/jmri.26284.
- Advanced Imaging of the Left Atrium with Cardiac Magnetic Resonance: A Review of Current and Emerging Methods and Clinical ApplicationsSoufer A, Peters D, Henry M, Baldassarre L. Advanced Imaging of the Left Atrium with Cardiac Magnetic Resonance: A Review of Current and Emerging Methods and Clinical Applications. Current Radiology Reports 2018, 6: 44. DOI: 10.1007/s40134-018-0303-7.
- Assessment of diastolic function and atrial remodeling by MRI – validation and correlation with echocardiography and filling pressureSeemann F, Baldassarre LA, Llanos‐Chea F, Gonzales RA, Grunseich K, Hu C, Sugeng L, Meadows J, Heiberg E, Peters DC. Assessment of diastolic function and atrial remodeling by MRI – validation and correlation with echocardiography and filling pressure. Physiological Reports 2018, 6: e13828. PMID: 30187654, PMCID: PMC6125607, DOI: 10.14814/phy2.13828.
- Reverse double inversion‐recovery: Improving motion robustness of cardiac T2‐weighted dark‐blood turbo spin‐echo sequenceHu C, Huber S, Latif SR, Santacana‐Laffitte G, Mojibian HR, Baldassarre LA, Peters DC. Reverse double inversion‐recovery: Improving motion robustness of cardiac T2‐weighted dark‐blood turbo spin‐echo sequence. Journal Of Magnetic Resonance Imaging 2017, 47: 1498-1508. PMID: 29112315, PMCID: PMC6346424, DOI: 10.1002/jmri.25886.
- Diagnosis of extensive myocardial infiltration by diffuse large B-cell lymphoma using 18F-fluorodeoxyglucose positron emission tomography (18-FDG PET)Higgins AY, Taylor EP, Baldassarre LA, Miller EJ, Rosenfeld LE. Diagnosis of extensive myocardial infiltration by diffuse large B-cell lymphoma using 18F-fluorodeoxyglucose positron emission tomography (18-FDG PET). Journal Of Nuclear Cardiology 2017, 25: 1869-1871. PMID: 29116563, DOI: 10.1007/s12350-017-1099-1.
- Serial Native T1 Mapping to Monitor Cardiac Response to Treatment in Light-Chain AmyloidosisHur DJ, Dicks DL, Huber S, Mojibian HR, Meadows JL, Seropian SE, Baldassarre LA. Serial Native T1 Mapping to Monitor Cardiac Response to Treatment in Light-Chain Amyloidosis. Circulation Cardiovascular Imaging 2016, 9: e004770. PMID: 27682238, DOI: 10.1161/circimaging.116.004770.
- Noninvasive Imaging to Evaluate Women With Stable Ischemic Heart DiseaseBaldassarre LA, Raman SV, Min JK, Mieres JH, Gulati M, Wenger NK, Marwick TH, Bucciarelli-Ducci C, Merz C, Itchhaporia D, Ferdinand KC, Pepine CJ, Walsh MN, Narula J, Shaw LJ, Committee A. Noninvasive Imaging to Evaluate Women With Stable Ischemic Heart Disease. JACC Cardiovascular Imaging 2016, 9: 421-435. PMID: 27056162, PMCID: PMC5486953, DOI: 10.1016/j.jcmg.2016.01.004.
- SCCT curriculum guidelines for general (level 1) cardiovascular CT training.Maroules CD, Cheezum MK, Joshi PH, Williams M, Simprini LA, Nelson KH, Bittencourt MS, Carr JJ, Weigold WG, Cury RC, Blankstein R, Abbara S. SCCT curriculum guidelines for general (level 1) cardiovascular CT training. Journal Of Cardiovascular Computed Tomography 2015, 9: 81-8. PMID: 25708013, DOI: 10.1016/j.jcct.2015.01.004.
- Imaging of the right heart--CT and CMR.Kochav J, Simprini L, Weinsaft JW. Imaging of the right heart--CT and CMR. Echocardiography (Mount Kisco, N.Y.) 2015, 32 Suppl 1: S53-68. PMID: 25244072, DOI: 10.1111/echo.12212.
- Routine cine-CMR for prosthesis-associated mitral regurgitation: a multicenter comparison to echocardiography.Simprini LA, Afroz A, Cooper MA, Klem I, Jensen C, Kim RJ, Srichai MB, Heitner JF, Sood M, Chandy E, Shah DJ, Lopez-Mattei J, Biederman RW, Grizzard JD, Fuisz A, Ghafourian K, Farzaneh-Far A, Weinsaft J. Routine cine-CMR for prosthesis-associated mitral regurgitation: a multicenter comparison to echocardiography. The Journal Of Heart Valve Disease 2014, 23: 575-82. PMID: 25799706, PMCID: PMC5057384.
- Geometry-independent inclusion of basal myocardium yields improved cardiac magnetic resonance agreement with echocardiography and necropsy quantified left-ventricular mass.Simprini LA, Goyal P, Codella N, Fieno DS, Afroz A, Mullally J, Cooper M, Wang Y, Finn JP, Devereux RB, Weinsaft JW. Geometry-independent inclusion of basal myocardium yields improved cardiac magnetic resonance agreement with echocardiography and necropsy quantified left-ventricular mass. Journal Of Hypertension 2013, 31: 2069-76. PMID: 24107735, PMCID: PMC4017912, DOI: 10.1097/HJH.0b013e328362d935.
- Mitral Apparatus Assessment by Delayed Enhancement CMR Relative Impact of Infarct Distribution on Mitral RegurgitationChinitz JS, Chen D, Goyal P, Wilson S, Islam F, Nguyen T, Wang Y, Hurtado-Rua S, Simprini L, Cham M, Levine RA, Devereux RB, Weinsaft JW. Mitral Apparatus Assessment by Delayed Enhancement CMR Relative Impact of Infarct Distribution on Mitral Regurgitation. JACC Cardiovascular Imaging 2013, 6: 220-234. PMID: 23489536, PMCID: PMC4048744, DOI: 10.1016/j.jcmg.2012.08.016.
- Scout view X-ray attenuation versus weight-based selection of reduced peak tube voltage in cardiac CT angiography.Ghafourian K, Younes D, Simprini LA, Weigold WG, Weissman G, Taylor AJ. Scout view X-ray attenuation versus weight-based selection of reduced peak tube voltage in cardiac CT angiography. JACC. Cardiovascular Imaging 2012, 5: 589-95. PMID: 22698527, DOI: 10.1016/j.jcmg.2011.12.022.
- Cardiac CT in women: clinical application and considerations.Simprini LA, Taylor AJ. Cardiac CT in women: clinical application and considerations. Journal Of Cardiovascular Computed Tomography 2012, 6: 71-7. PMID: 22369778, DOI: 10.1016/j.jcct.2012.01.003.
- The relationship between subclinical atherosclerosis, non-high-density lipoprotein cholesterol, exercise, and diet among male participants of the PACC Project.Simprini LA, Villines TC, Rich M, Taylor AJ. The relationship between subclinical atherosclerosis, non-high-density lipoprotein cholesterol, exercise, and diet among male participants of the PACC Project. Journal Of Clinical Lipidology 2012, 6: 174-9. PMID: 22385551, DOI: 10.1016/j.jacl.2011.11.005.
- Prospective evaluation of the updated 2010 ACCF Cardiac CT Appropriate Use Criteria.Rich ME, Utsunomiya D, Simprini LA, Weigold WG, Weissman G, Taylor AJ. Prospective evaluation of the updated 2010 ACCF Cardiac CT Appropriate Use Criteria. Journal Of Cardiovascular Computed Tomography 2012, 6: 108-12. PMID: 22440426, DOI: 10.1016/j.jcct.2012.02.003.
- Catheter-directed ultrasound-accelerated thrombolysis for the treatment of acute pulmonary embolism.Engelhardt TC, Taylor AJ, Simprini LA, Kucher N. Catheter-directed ultrasound-accelerated thrombolysis for the treatment of acute pulmonary embolism. Thrombosis Research 2011, 128: 149-54. PMID: 21641020, DOI: 10.1016/j.thromres.2011.05.014.
- Nonobstructive coronary artery disease as detected by 64-detector row cardiac computed tomographic angiography is associated with increased left ventricular mass.Lin FY, Nicolo D, Devereux RB, Labounty TM, Dunning A, Gomez M, Koduru S, Choi JH, Weinsaft JW, Simprini LA, Callister TQ, Shaw LJ, Berman DS, Min JK. Nonobstructive coronary artery disease as detected by 64-detector row cardiac computed tomographic angiography is associated with increased left ventricular mass. Journal Of Cardiovascular Computed Tomography 2011, 5: 158-64. PMID: 21376693, DOI: 10.1016/j.jcct.2011.01.006.
- The right sided great vessels by cardiac multidetector computed tomography: normative reference values among healthy adults free of cardiopulmonary disease, hypertension, and obesity.Lin FY, Devereux RB, Roman MJ, Meng J, Jow VM, Simprini L, Jacobs A, Weinsaft JW, Shaw LJ, Berman DS, Callister TQ, Min JK. The right sided great vessels by cardiac multidetector computed tomography: normative reference values among healthy adults free of cardiopulmonary disease, hypertension, and obesity. Academic Radiology 2009, 16: 981-7. PMID: 19394871, DOI: 10.1016/j.acra.2009.02.013.
- Twenty-five novel HLA-B alleles.Steiner NK, Gans C, Baldassarre L, Bradshaw D, Rizzo M, Divekar S, Koester R, Ng J, Hartzman RJ, Hurley CK. Twenty-five novel HLA-B alleles. Tissue Antigens 2003, 62: 263-6. PMID: 12956882, DOI: 10.1034/j.1399-0039.2003.00095.x.
- Seventeen novel HLA-A alleles.Steiner NK, Rizzo M, Bradshaw D, Baldassarre L, Jones P, Koester R, Ng J, Hartzman RJ, Hurley CK. Seventeen novel HLA-A alleles. Tissue Antigens 2003, 62: 256-8. PMID: 12956880, DOI: 10.1034/j.1399-0039.2003.00090.x.
- Limited diversity of HLA-DRB1*02 alleles and DRB1-DRB5 haplotype associations in four United States population groups.Baldassarre LA, Steiner NK, Jones P, Tang T, Slack R, Ng J, Hartzman RJ, Hurley CK. Limited diversity of HLA-DRB1*02 alleles and DRB1-DRB5 haplotype associations in four United States population groups. Tissue Antigens 2003, 61: 249-52. PMID: 12694574, DOI: 10.1034/j.1399-0039.2003.00018.x.
- Novel HLA-B alleles formed by an inter-locus recombination with HLA-C, HLA-B*0713 and B*6702.Steiner NK, Baldassarre L, Koester R, Ng J, Hartzman RJ, Hurley CK. Novel HLA-B alleles formed by an inter-locus recombination with HLA-C, HLA-B*0713 and B*6702. Tissue Antigens 2002, 59: 148-50. PMID: 12028546, DOI: 10.1034/j.1399-0039.2002.590215.x.
- Twenty-nine new HLA-B alleles associated with antigens in the 5C CREG.Steiner NK, Kosman C, Jones PF, Gans CP, Rodriguez-Marino SG, Rizzuto G, Baldassarre LA, Edson S, Koester R, Sese D, Mitton W, Ng J, Hartzman RJ, Hurley CK. Twenty-nine new HLA-B alleles associated with antigens in the 5C CREG. Tissue Antigens 2001, 57: 481-5. PMID: 11556976, DOI: 10.1034/j.1399-0039.2001.057005481.x.
- Novel HLA-B alleles associated with antigens in the 8C CREG.Steiner NK, Gans CP, Kosman C, Baldassarre LA, Edson S, Jones PF, Rizzuto G, Pimtanothai N, Koester R, Mitton W, Ng J, Hartzman RJ, Hurley CK. Novel HLA-B alleles associated with antigens in the 8C CREG. Tissue Antigens 2001, 57: 373-5. PMID: 11380951, DOI: 10.1034/j.1399-0039.2001.057004373.x.
Clinical Trials
Conditions | Study Title |
---|---|
Unknown Sites | Advanced Cardiovascular Magnetic Resonance for Detection of Programmed Cell Death Protein-1 Deficient Myocarditis |